Infermedica

AI triage engine · Primary-care triage

Overview

AI medical-guidance platform (symptom checking and triage) used by insurers and health systems worldwide — one of Poland's best-funded digital-health exports.

What they do

Infermedica is a Wroclaw-founded digital-health company building AI-powered symptom checking and triage. Its core products are the consumer-facing Symptom Checker and a developer Triage API, supported by an Intake and care-navigation layer that directs patients to the right level of care. The platform is sold primarily to health insurers (payers), provider networks, telemedicine vendors and government health services, and is deployed in dozens of countries and multiple languages.

Lead program & status

The flagship offering is the medical-knowledge engine powering virtual triage and symptom assessment, embedded in partner apps and call-centre workflows. Infermedica raised a $10.25M Series A in 2020 (EBRD and Heal Capital leading) and a $30M Series B in February 2022 led by One Peak, bringing total funding to roughly $45M and making it one of Poland's best-funded digital-health exports. As of its 2024 review, the company expanded into the public-health and government sector and signalled work toward certifying its conversational tool as a regulated medical device.

Why it matters

By automating front-door triage, Infermedica aims to cut unnecessary visits and steer patients to appropriate care, a scalable answer to clinician shortages and rising demand. Its API-first model lets large payers and health systems integrate medical guidance at scale.

FAQ

What does Infermedica's Symptom Checker do?

It collects a patient's symptoms through a guided interview and uses Infermedica's medical-reasoning engine to suggest possible conditions and recommend an appropriate level of care (triage), helping route people before they reach a clinician.

Who uses Infermedica?

Mainly health insurers, provider networks, telemedicine companies and government health services worldwide, who embed its Triage API and Symptom Checker into their own apps and care-navigation workflows.

How much funding has Infermedica raised?

Approximately $45M in total, including a $10.25M Series A in 2020 and a $30M Series B in February 2022 led by One Peak, making it one of Poland's best-funded digital-health companies.

Technology

Infermedica works in AI-Driven Drug Discovery — Compressing years of trial-and-error chemistry into months of computation.

Related companies

Company website / source ↗ Open the interactive map →